Key Dates

Related Announcements

• December 28, 2023 - Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional. See NOFO RFA-FD-24-029 

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this Notice is to update Key Dates as well as verbiage under the "Additional Information on Eligibility" section shown on this NOFO.

Currently reads:

Letter of Intent Due Date(s)        February 5, 2024

Application Due Date(s)              March 4, 2024

Scientific Merit Review                April 2024

Expiration Date                            March 5, 2024

Modified to read:

Letter of Intent Due Date(s)        February 21, 2024

Application Due Date(s)              April 2, 2024

Scientific Merit Review                 April - May 2024

Expiration Date                            April 3, 2024

Currently reads:

3. Additional Information on Eligibility
Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

Modified to read:

3. Additional Information on Eligibility
Number of Applications
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed. Institutions interested in involving multiple offices/departments (within their institution) should internally coordinate and choose one (1) entity to apply.

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Terrin Brown
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: Terrin.Brown@fda.hhs.gov